{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:30:38Z","timestamp":1788442238643,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT10545"],"award-info":[{"award-number":["IT10545"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The positron emission tomography (PET) ligand <jats:sup>68<\/jats:sup>Ga-Glu-urea-Lys(Ahx)-HBED-CC (<jats:sup>68<\/jats:sup>Ga-PSMA-11) targets the prostate-specific membrane antigen (PSMA), upregulated in prostate cancer cells. Although <jats:sup>68<\/jats:sup>Ga-PSMA-11 PET is widely used in research and clinical practice, full kinetic modeling has not yet been reported nor have simplified methods for quantification been validated. The aims of our study were to quantify <jats:sup>68<\/jats:sup>Ga-PSMA-11 uptake in primary prostate cancer patients using compartmental modeling with arterial blood sampling and to validate the use of standardized uptake values (SUV) and image-derived blood for quantification.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Fifteen patients with histologically proven primary prostate cancer underwent a 60-min dynamic <jats:sup>68<\/jats:sup>Ga-PSMA-11 PET scan of the pelvis with axial T1 Dixon, T2, and diffusion-weighted magnetic resonance (MR) images acquired simultaneously. Time-activity curves were derived from volumes of interest in lesions, normal prostate, and muscle, and mean SUV calculated. In total, 18 positive lesions were identified on both PET and MR. Arterial blood activity was measured by automatic arterial blood sampling and manual blood samples were collected for plasma-to-blood ratio correction and for metabolite analysis. The analysis showed that <jats:sup>68<\/jats:sup>Ga-PSMA-11 was stable in vivo. Based on the Akaike information criterion, <jats:sup>68<\/jats:sup>Ga-PSMA-11 kinetics were best described by an irreversible two-tissue compartment model. The rate constants <jats:italic>K<\/jats:italic><jats:sub>1<\/jats:sub> and <jats:italic>k<\/jats:italic><jats:sub>3<\/jats:sub> and the net influx rate constants <jats:italic>K<\/jats:italic><jats:sub>i<\/jats:sub> were all significantly higher in lesions compared to normal tissue (<jats:italic>p<\/jats:italic> &lt; 0.05). <jats:italic>K<\/jats:italic><jats:sub>i<\/jats:sub> derived using image-derived blood from an MR-guided method showed excellent agreement with <jats:italic>K<\/jats:italic><jats:sub>i<\/jats:sub> derived using arterial blood sampling (intraclass correlation coefficient = 0.99). SUV correlated significantly with K<jats:sub>i<\/jats:sub> with the strongest correlation of scan time-window 30\u201345 min (rho 0.95, <jats:italic>p<\/jats:italic> &lt; 0.001). Both <jats:italic>K<\/jats:italic><jats:sub>i<\/jats:sub> and SUV correlated significantly with serum prostate specific antigen (PSA) level and PSA density.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p><jats:sup>68<\/jats:sup>Ga-PSMA-11 kinetics can be described by an irreversible two-tissue compartment model. An MR-guided method for image-derived blood provides a non-invasive alternative to blood sampling for kinetic modeling studies. SUV showed strong correlation with <jats:italic>K<\/jats:italic><jats:sub>i<\/jats:sub> and can be used in routine clinical settings to quantify <jats:sup>68<\/jats:sup>Ga-PSMA-11 uptake.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13550-020-0594-6","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T18:02:44Z","timestamp":1583431364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate cancer patients"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8718-0582","authenticated-orcid":false,"given":"Anna","family":"Ringheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme de Carvalho","family":"Campos Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udunna","family":"Anazodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lumeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Livorsi","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taise","family":"Vitor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine Minaif","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cl\u00e1udia Camargo","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marycel Figols","family":"de Barboza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Lima","family":"Fuscaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Caserta","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Roberto","family":"Colombo Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo Hueb","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"594_CR1","doi-asserted-by":"publisher","first-page":"9578","DOI":"10.1073\/pnas.1106383108","volume":"108","author":"MJ Evans","year":"2011","unstructured":"Evans MJ, Smith-Jones PM, Wongvipat J, Navarro V, Kim S, Bander NH, et al. Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen. Proc Natl Acad Sci U S A. 2011;108:9578\u201382. https:\/\/doi.org\/10.1073\/pnas.1106383108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"594_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","volume":"41","author":"A Afshar-Oromieh","year":"2014","unstructured":"Afshar-Oromieh A, Zechmann CM, Malcher A, Eder M, Eisenhut M, Linhart HG, et al. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2014;41:11\u201320. https:\/\/doi.org\/10.1007\/s00259-013-2525-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"594_CR3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","volume":"70","author":"M Eiber","year":"2016","unstructured":"Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I, et al. Simultaneous (68)Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer. Eur Urol. 2016;70:829\u201336. https:\/\/doi.org\/10.1016\/j.eururo.2015.12.053.","journal-title":"Eur Urol"},{"key":"594_CR4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2214\/ajr.18.19585","volume":"211","author":"A Jena","year":"2018","unstructured":"Jena A, Taneja R, Taneja S, Singh A, Kumar V, Agarwal A, et al. Improving diagnosis of primary prostate cancer with combined (68)Ga-prostate-specific membrane antigen-HBED-CC simultaneous PET and multiparametric MRI and clinical parameters. AJR Am J Roentgenol. 2018;211:1246\u201353. https:\/\/doi.org\/10.2214\/ajr.18.19585.","journal-title":"AJR Am J Roentgenol"},{"key":"594_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3413\/Nukmed-0850-16-09","volume":"56","author":"S Lutje","year":"2017","unstructured":"Lutje S, Cohnen J, Gomez B, Gruneisen J, Sawicki L, Rubben H, et al. Integrated (68)Ga-HBED-CC-PSMA-PET\/MRI in patients with suspected recurrent prostate cancer. Nuklearmedizin. 2017;56:73\u201381. https:\/\/doi.org\/10.3413\/Nukmed-0850-16-09.","journal-title":"Nuklearmedizin."},{"key":"594_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1148\/radiol.2018180788","volume":"289","author":"RM Hicks","year":"2018","unstructured":"Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, et al. Diagnostic accuracy of (68)Ga-PSMA-11 PET\/MRI compared with multiparametric MRI in the detection of prostate cancer. Radiology. 2018;289:730\u20137. https:\/\/doi.org\/10.1148\/radiol.2018180788.","journal-title":"Radiology."},{"key":"594_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11307-011-0514-2","volume":"14","author":"G Tomasi","year":"2012","unstructured":"Tomasi G, Turkheimer F, Aboagye E. Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future. Mol Imaging Biol. 2012;14:131\u201346. https:\/\/doi.org\/10.1007\/s11307-011-0514-2.","journal-title":"Mol Imaging Biol"},{"key":"594_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/RCT.0b013e31826bdd09","volume":"36","author":"ST Feng","year":"2012","unstructured":"Feng ST, Cui M, Gao J, Wu B, Sha W, Huang B. Image-derived arterial input function in dynamic positron emission tomography-computed tomography: a method using both positron emission tomographic and computed tomographic images. J Comput Assist Tomogr. 2012;36:762\u20137. https:\/\/doi.org\/10.1097\/RCT.0b013e31826bdd09.","journal-title":"J Comput Assist Tomogr"},{"key":"594_CR9","doi-asserted-by":"publisher","first-page":"A80","DOI":"10.1186\/2197-7364-2-s1-a80","volume":"2","author":"U Anazodo","year":"2015","unstructured":"Anazodo U, Kewin M, Finger E, Thiessen J, Hadway J, Butler J, et al. Preliminary evaluation of MRI-derived input function for quantitative measurement of glucose metabolism in an integrated PET-MRI. EJNMMI Phys. 2015;2:A80. https:\/\/doi.org\/10.1186\/2197-7364-2-s1-a80.","journal-title":"EJNMMI Phys"},{"key":"594_CR10","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1007\/s00259-016-3424-3","volume":"43","author":"CH Pfob","year":"2016","unstructured":"Pfob CH, Ziegler S, Graner FP, Kohner M, Schachoff S, Blechert B, et al. Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer. Eur J Nucl Med Mol Imaging. 2016;43:1962\u201370. https:\/\/doi.org\/10.1007\/s00259-016-3424-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"594_CR11","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1097\/RLU.0000000000001349","volume":"41","author":"C Sachpekidis","year":"2016","unstructured":"Sachpekidis C, Kopka K, Eder M, Hadaschik BA, Freitag MT, Pan L, et al. 68Ga-PSMA-11 Dynamic PET\/CT Imaging in Primary Prostate Cancer. Clin Nucl Med. 2016;41:e473\u2013e9. https:\/\/doi.org\/10.1097\/RLU.0000000000001349.","journal-title":"Clin Nucl Med"},{"key":"594_CR12","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s00259-015-3302-4","volume":"43","author":"C Sachpekidis","year":"2016","unstructured":"Sachpekidis C, Eder M, Kopka K, Mier W, Hadaschik BA, Haberkorn U, et al. (68)Ga-PSMA-11 dynamic PET\/CT imaging in biochemical relapse of prostate cancer. Eur J Nucl Med Mol Imaging. 2016;43:1288\u201399. https:\/\/doi.org\/10.1007\/s00259-015-3302-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"594_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1021\/bc200279b","volume":"23","author":"M Eder","year":"2012","unstructured":"Eder M, Schafer M, Bauder-Wust U, Hull WE, Wangler C, Mier W, et al. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging. Bioconjug Chem. 2012;23:688\u201397. https:\/\/doi.org\/10.1021\/bc200279b.","journal-title":"Bioconjug Chem"},{"key":"594_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging-reporting and data system: 2015, Version 2. Eur Urol. 2016;69:16\u201340. https:\/\/doi.org\/10.1016\/j.eururo.2015.08.052.","journal-title":"Eur Urol"},{"key":"594_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00259-010-1443-z","volume":"37","author":"E Croteau","year":"2010","unstructured":"Croteau E, Lavallee E, Labbe SM, Hubert L, Pifferi F, Rousseau JA, et al. Image-derived input function in dynamic human PET\/CT: methodology and validation with 11C-acetate and 18F-fluorothioheptadecanoic acid in muscle and 18F-fluorodeoxyglucose in brain. Eur J Nucl Med Mol Imaging. 2010;37:1539\u201350. https:\/\/doi.org\/10.1007\/s00259-010-1443-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"594_CR16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/tac.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19:716\u201323. https:\/\/doi.org\/10.1109\/tac.1974.1100705.","journal-title":"IEEE Trans Autom Control"},{"key":"594_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40658-017-0197-0","volume":"4","author":"SSV Golla","year":"2017","unstructured":"Golla SSV, Adriaanse SM, Yaqub M, Windhorst AD, Lammertsma AA, van Berckel BNM, et al. Model selection criteria for dynamic brain PET studies. EJNMMI Phys. 2017;4:30. https:\/\/doi.org\/10.1186\/s40658-017-0197-0.","journal-title":"EJNMMI Phys"},{"key":"594_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","volume":"3","author":"CS Patlak","year":"1983","unstructured":"Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1\u20137. https:\/\/doi.org\/10.1038\/jcbfm.1983.1.","journal-title":"J Cereb Blood Flow Metab"},{"key":"594_CR19","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017."},{"key":"594_CR20","unstructured":"Ringheim A, Campos Neto G De C, Anazodo UC, Cui L, da Cunha ML, Vitor T, et al.. Pharmacokinetic modeling of 68Ga-PSMA-11 in primary prostate cancer patients [Internet]. figshare; 2019 [cited 2019Nov25].. Available from: https:\/\/figshare.com\/articles\/Pharmacokinetic_modeling_of_68Ga_PSMA-11_in_primary_prostate_cancer_patients\/10265825\/2"},{"key":"594_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/jcb.10661","volume":"91","author":"A Ghosh","year":"2004","unstructured":"Ghosh A, Heston WD. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem. 2004;91:528\u201339. https:\/\/doi.org\/10.1002\/jcb.10661.","journal-title":"J Cell Biochem"},{"key":"594_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5114\/wo.2013.35272","volume":"17","author":"E Luczynska","year":"2013","unstructured":"Luczynska E, Aniol J. Neoangiogenesis in prostate cancer. Contemporary oncology (Poznan, Poland). 2013;17:229\u201333. https:\/\/doi.org\/10.5114\/wo.2013.35272.","journal-title":"Contemporary oncology (Poznan, Poland)"},{"key":"594_CR23","unstructured":"National Heart, Lung, and Blood Institute: Types of blood tests. http:\/\/www.nhlbi.nih.gov\/health\/health-topics\/topics\/bdt\/types. Accessed 31 Oct 2019."},{"key":"594_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2967\/jnumed.114.148007","volume":"56","author":"EE Verwer","year":"2015","unstructured":"Verwer EE, Oprea-Lager DE, van den Eertwegh AJ, van Moorselaar RJ, Windhorst AD, Schwarte LA, et al. Quantification of 18F-fluorocholine kinetics in patients with prostate cancer. J Nucl Med. 2015;56:365\u201371. https:\/\/doi.org\/10.2967\/jnumed.114.148007.","journal-title":"J Nucl Med"},{"key":"594_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","volume":"40","author":"A Afshar-Oromieh","year":"2013","unstructured":"Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, et al. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging. 2013;40:486\u201395. https:\/\/doi.org\/10.1007\/s00259-012-2298-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"594_CR26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","volume":"44","author":"Wolfgang P. Fendler","year":"2017","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, et al. (68)Ga-PSMA PET\/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017;44:1014-24. doi:https:\/\/doi.org\/10.1007\/s00259-017-3670-z.","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"594_CR27","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00259-016-3419-0","volume":"43","author":"A Afshar-Oromieh","year":"2016","unstructured":"Afshar-Oromieh A, Hetzheim H, Kubler W, Kratochwil C, Giesel FL, Hope TA, et al. Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing. Eur J Nucl Med Mol Imaging. 2016;43:1611\u201320. https:\/\/doi.org\/10.1007\/s00259-016-3419-0.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-0594-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-020-0594-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-0594-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:14:17Z","timestamp":1614039257000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-020-0594-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["594"],"URL":"https:\/\/doi.org\/10.1186\/s13550-020-0594-6","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"assertion":[{"value":"27 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of Hospital Israelita Albert Einstein (reference number 58175716.9.0000.0071) and informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}